Travere Therapeutics shares owned by Hanson McClain Advisors
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Hanson McClain Advisors
from 13F filings
Historical chart of Hanson McClain Advisors investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Travere Therapeutics by Hanson McClain Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $7.9k | 568 | 13.99 |
2024-06-30 | $5.6k | 568 | 9.80 |
2023-09-30 | $429 | 48 | 8.96 |
2023-06-30 | $291 | 19 | 15.37 |
2023-03-31 | $945 | 42 | 22.50 |
2022-09-30 | $1.0k | 50 | 20.00 |
2022-06-30 | $0 | 17 | 0.00 |